Direct medical costs associated with the extrahepatic manifestations of hepatitis C virus infection in France.

about

Direct medical costs associated with the extrahepatic manifestations of hepatitis C virus infection in France.

Item

http://www.wikidata.org/entity/Q45326148

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Direct medical costs associate ...... s C virus infection in France.

@en

Direct medical costs associate ...... s C virus infection in France.

@nl

type

Item

label

Direct medical costs associate ...... s C virus infection in France.

@en

Direct medical costs associate ...... s C virus infection in France.

@nl

prefLabel

Direct medical costs associate ...... s C virus infection in France.

@en

Direct medical costs associate ...... s C virus infection in France.

@nl

P1476

Direct medical costs associate ...... is C virus infection in France

@en

P2093

D Saadoun

http://www.w3.org/2001/XMLSchema#string

M Vautier

http://www.w3.org/2001/XMLSchema#string

P Cacoub

http://www.w3.org/2001/XMLSchema#string

P2860

Extrahepatic manifestations of chronic hepatitis C virus infection

Hepatitis C.

Patient-reported and economic outcomes related to sofosbuvir and ledipasvir treatment for chronic hepatitis C.

Extrahepatic manifestations of Hepatitis C Virus infection: a general overview and guidelines for a clinical approach.

Hepatitis C virus syndrome: A constellation of organ- and non-organ specific autoimmune disorders, B-cell non-Hodgkin's lymphoma, and cancer

Treatment of hepatitis C virus-associated mixed cryoglobulinemia with direct-acting antiviral agents.

Viral clearance is associated with improved insulin resistance in genotype 1 chronic hepatitis C but not genotype 2/3

Extrahepatic manifestations of chronic hepatitis C virus infection.

Antiviral treatment for hepatitis C virus infection is associated with improved renal and cardiovascular outcomes in diabetic patients.

Extrahepatic Manifestations of Hepatitis C: A Meta-analysis of Prevalence, Quality of Life, and Economic Burden.

P304

123-128

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/APT.14382

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Zobair M Younossi

Anne Claire Desbois

P577

2017-10-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29044584

http://www.w3.org/2001/XMLSchema#string